Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page footer revision number is updated from v3.5.2 to v3.5.3, reflecting a website build/version change rather than any modification to the study details.SummaryDifference0.0%

- Check16 days agoChange DetectedTemuco, Chile location updated from 'Temuco, Región de la Araucanía, Chile, 4780000' to 'Temuco, Araucania, Chile, 4780000'. Revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedLocation entry updated from Padua, Italy, 35128 to Padova, Italy, 35128 in the study's locations list.SummaryDifference0.0%

- Check45 days agoChange DetectedNapoli, Italy, 80131 was renamed to Naples, Italy, 80131, and the page revision updated to v3.5.0.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded a 'Gastric cancer' tag and a link to the Genetic and Rare Diseases Information Center; page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.